Tesla and Power in Muscle Stimulation

Tesla (symbol T) is the SI (International System) unit measuring magnetic induction or magnetic flux density. One Tesla = 1 Weber per square meter = 1 kilogram per ampere-second² (kg/(A·s²)). Historically named in honor of Nikola Tesla (electrical physicist). In EMT/HIFEM, the power of magnetic field described in Tesla determines intensity of tissue electrical induction, which directly determines amplitude of muscle contractions. ICESLIM IV = 1.9 Tesla; competitive systems typically 1.0-1.8 Tesla; experimental research 2.5-3.0 Tesla (hyperthermia risk).

FARADAY'S LAW OF INDUCTION:

Oscillating magnetic field induces circular electric field: ∮E⃗·dl⃗ = -dΦ_B/dt

Where Φ_B = ∫∫B⃗·dA⃗ (magnetic flux = B density × perpendicular area).

Rate of magnetic flux variation (dΦ/dt = d(B·A)/dt = A·(dB/dt) if A constant) creates magnetic gradient (dB/dt).

CRITICAL MAGNETIC GRADIENT:

For HIFEM 1.9T, oscillation frequency 150Hz means:

B(t) = 1.9sin(2π·150·t) Tesla

dB/dt = 1.9·2π·150·cos(2π·150·t) = 1.9·942·cos(...) ≈ 1800 Tesla/second

Magnetic gradient 1800 T/s induces circular electric field:

E = -(1/2π·r)·(dB/dt) = 1800/(2π·r) Volts/meter

For muscle tissue r = 2cm (coil center distance), E ≈ 14 kV/m

This 14 kV/m electric field exceeds muscle membrane depolarization threshold (~10-15 kV/m), causing sodium channel opening, contraction. RESULT: magnetic gradient dB/dt directly proportional to depolarization amplitude, thus contraction amplitude.

EMPIRICAL TESLA-CONTRACTION RELATIONSHIP:

Clinical data suggest quasi-linear relationship:

• 1.0 Tesla: 10-12,000 contractions per session (weak-moderate)
• 1.5 Tesla: 16-18,000 contractions per session (moderate-good)
• 1.9 Tesla: 20-22,000 contractions per session (excellent, 100% recruitment)
• 2.5 Tesla: 22-25,000 contractions per session (theoretical optimal, not large clinical use)

EFFECT SATURATION:

However, Tesla increase >2.0 yields diminishing returns (sigmoidal curve, not linear). 2.5T vs 1.9T = contraction increase only 10-15%, while cost+thermal risk increases 30-50%. Reason: motoneuron recruitment saturation (100% fiber recruitment reached ~1.8-1.9T, additional Tesla recruits few new fibers).

CLINICAL TESLA SELECTION: balance of efficacy-safety-tolerance

• ADVANTAGE: low cost, excellent tolerance (minimal discomfort), excellent safety (no hyperthermia risk)
• DISADVANTAGE: insufficient contractions (12,000 vs 20,000), reduced hypertrophy (10-14% vs 16-20% 1.9T), poor results (patient dissatisfaction, moderate efficacy)
• INDICATION: high-sensitivity patients to cold/discomfort, moderate results acceptable, limited budgets

• ADVANTAGE: moderate cost, good efficacy (16-18k contractions), good tolerance
• DISADVANTAGE: intermediate hypertrophy (14-16% vs 16-20% 1.9T), not "sweet spot" optimal
• INDICATION: patient efficacy-tolerance balance, second choice to 1.9T

• ADVANTAGE: maximum contractions (20-22k), hypertrophy 16-20%, indirect lipolysis 25-30%, spectacular patient results, 90%+ satisfaction
• DISADVANTAGE: higher cost, moderate comfort (possible paresthesia), minimal hyperthermia risk (if duration <30min)
• INDICATION: patients seeking optimal results, good thermal tolerance, standard budget
• RATIONALE: 1.9T represents Pareto optimal inversion point for efficacy-cost-safety

• ADVANTAGE: theoretical maximum contractions (but saturation diminishing returns), potential hypertrophy 20-22%
• DISADVANTAGE: very high cost, mild cutaneous hyperthermia risk, zero evidence of 1.9T superiority, high maintenance complexity
• INDICATION: currently no clinical indication (not FDA/CE approved), used in university research only

CLINICAL CONCLUSION: